Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Mohammadreza Barzegartahamtan"'
Publikováno v:
Caspian Journal of Internal Medicine, Vol 11, Iss 3, Pp 324-328 (2020)
Background: Prostate specific antigen (PSA) is an important biomarker to monitor patients after treated with radiation therapy (RT). The aim of this study is to evaluate the relationship between the PSA data and prostate cancer recurrence using the j
Externí odkaz:
https://doaj.org/article/e83be8b21cb54f36a952142f9a24e640
Publikováno v:
Tehran University Medical Journal, Vol 77, Iss 12, Pp 746-753 (2020)
Background: The rate of recurrence and mortality in high-risk prostate cancer remains high. On the other hand, the use of chemotherapy in metastatic prostate cancer has improved overall survival of patients. The aim of this study was to evaluate the
Externí odkaz:
https://doaj.org/article/1ee00468dea244b3baf680e431be2b47
Autor:
Reza Ali Mohammadpour, Jamshid Yazdani- Charati, SZahra Faghani, Ahad Alizadeh, Mohammadreza Barzegartahamtan
Publikováno v:
PeerJ, Vol 7, p e7172 (2019)
Purpose One of the characteristics of Prostate-Specific Antigen (PSA) is PSA slope. It is the rate of diminishing PSA marker over time after radiotherapy (RT) in prostate cancer (PC) patients. The purpose of this study was to evaluate the relationshi
Externí odkaz:
https://doaj.org/article/48f7d9f169f44f2aac174992e7687a07
Publikováno v:
Archives of Iranian medicine. 23(8)
Publikováno v:
Cancer radiotherapie : journal de la Societe francaise de radiotherapie oncologique. 22(1)
Purpose Historically, electron boost dose mainly was delivered by a direct field in adjuvant radiotherapy of breast cancer. In this prospective study, we investigated direct electron field, in terms of optimal coverage of tumour bed volume following
Autor:
Ahmad Ameri, Hamidreza Dehghan, M. Aloosh, M. Ghavamnasiri, Mohammadreza Barzegartahamtan, Ahmadreza Sebzari, Kambiz Novin, Reza Ali Mohammadpour
Publikováno v:
Clinical oncology (Royal College of Radiologists (Great Britain)). 30(4)
Aims Growth of the cancer incidence rate in Iran has been very high in recent years. Therefore, the Iranian health care system should be prepared for the treatment of a huge number of patients in the foreseeable future. One of the most important trea
Autor:
Barzegartahamtan, Mohammadreza1,2 mohammadtahamtan@sbmu.ac.ir, Mahdavi, Seyed Rabi3, Haddad, Peiman4
Publikováno v:
Archives of Iranian Medicine (AIM). Aug2020, Vol. 23 Issue 8, p572-572. 1p.
Autor:
حمیدرضا میرزایی1, محمدرضا برزگرتهمتن2,3 mohammadtahamtan@sbmu.ac.ir
Publikováno v:
Tehran University Medical Journal. Mar2020, Vol. 77 Issue 12, p746-753. 8p.